COVID-19 Research Resources
A curated list of research resources around guidelines, policies, and procedures related to COVID-19, drawn from Harvard University, affiliated academic healthcare centers, and government funding agencies

Training and tools for researchers like you. Pathfinder
Pathfinder Overview Pathfinder Overview
Basic Scientific Discovery
Clinical Insights
Implications for Practice
Implications for Population Health
Improved Global Health
Implications for Practice


Genetic risk testing: Can it help slow the diabetes epidemic?Genetic risk testing: Can it help slow the diabetes epidemic?

Genetic risk testing: Can it help slow the diabetes epidemic?

Researcher: Richard Grant, MD

Affiliation: Massachusetts General Hospital

Title: Co-director, Disease Management Unit, MGH Clinical Research Program
Assistant Professor of Medicine, Harvard Medical School

Research Summary:
Dr. Grant is studying whether genetic testing can motivate patients at risk for diabetes to adopt preventive lifestyle changes.


How can T3 research impact patients' lives?

A big part of effective T3 research is not just to take the new scientific evidence and put it into practice, but to take practice and work backwards and ask yourself, "How do patients really interpret new information, and what actually is going to make change?"

How does that perspective shape your work?

I'm very interested in improving the care of my patients, and in some ways there's a really close connection between my clinical practice and the research that I do. Many of my patients are overweight and at risk for diabetes, and I'm always interested in ways to make them more motivated, help them to really achieve a healthier lifestyle.

What is innovative about your study?

Most genetic counseling aims to provide information and let the patient decide what to do, but here… the genetic counselor is both giving the information and also using that information to encourage behavior change.

Implications for Population Health